IRADIMED CORP

IRADIMED Corporation develops and manufactures MRI-compatible medical devices designed for use in magnetic resonance imaging environments. The company's primary product is the MRidium MRI-compatible intravenous infusion pump system, which includes associated disposable IV tubing sets for drug delivery during MRI procedures. The company also produces MRI-compatible patient vital signs monitoring systems and ferromagnetic detection devices, along with complementary products such as non-magnetic IV poles, wireless remote displays and controls, side car pump modules, and SpO2 monitoring systems with sensors and accessories.

The company operates primarily through direct sales channels, utilizing field sales representatives, regional sales directors, and clinical application specialists, supplemented by independent distributors. Its customer base comprises hospitals, acute care facilities, and outpatient imaging centers across the United States and internationally. The device portfolio addresses the specialized infrastructure requirements of MRI departments, where standard medical equipment cannot be used due to the strong magnetic fields present in imaging suites.

Incorporated in Delaware in 1992, the company maintains headquarters in Orlando, Florida. IRADIMED is traded on the Nasdaq stock exchange with a market capitalization of approximately $1.3 billion.